Assessing Transcytosis of E. coli Across Intestinal Epithelial Monolayers
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:28 min • September 26th, 2025
Loading...
Overview
This study investigates the transcytosis of E. coli across intestinal epithelial cells. By measuring electrical resistance and counting bacterial colonies, the experiment assesses the integrity of the epithelial barrier during bacterial transport.
Key Study Components
Area of Science
- Microbiology
- Cell Biology
- Immunology
Background
- E. coli can cause bloodstream infections, particularly in newborns.
- Understanding bacterial transcytosis is crucial for developing therapeutic strategies.
- The integrity of the intestinal barrier is vital for preventing infections.
- Transcytosis involves the transport of substances across a cell layer.
Purpose of Study
- To evaluate the transcytosis mechanism of E. coli in intestinal epithelial cells.
- To measure the impact of bacterial adhesion on epithelial integrity.
- To quantify the extent of bacterial transport across the epithelial barrier.
Methods Used
- Centrifugation of E. coli cultures to isolate bacteria.
- Use of transwell inserts with intestinal epithelial cell monolayers.
- Measurement of electrical resistance to confirm monolayer integrity.
- Colony counting on agar plates to quantify transcytosis.
Main Results
- Stable electrical resistance indicates intact epithelial monolayer during experiments.
- Quantification of bacterial colonies reveals the extent of transcytosis.
- Results show a time-dependent increase in bacterial transport.
- Control wells provide baseline data for comparison.
Conclusions
- The study successfully demonstrates E. coli transcytosis across intestinal epithelial cells.
- Findings contribute to understanding bacterial pathogenesis in bloodstream infections.
- Future research may explore therapeutic interventions to enhance barrier function.
Frequently Asked Questions
What is transcytosis?
Transcytosis is the process by which substances are transported across a cell layer.
Why is the integrity of the epithelial barrier important?
An intact epithelial barrier prevents pathogens from entering the bloodstream and causing infections.
How is bacterial transcytosis measured in this study?
Bacterial transcytosis is measured by counting colonies on agar plates after incubation.
What role does electrical resistance play in this experiment?
Electrical resistance measurements confirm the integrity of the epithelial cell monolayer during the experiment.
What are the implications of this research?
The findings may inform therapeutic strategies to enhance intestinal barrier function and prevent infections.
Executive Industry Relevance
Assessing bacterial transcytosis across intestinal epithelial monolayers provides a mechanistic model for evaluating pathogen-host interactions relevant to neonatal sepsis and gastrointestinal barrier function. This assay enables early-stage target validation by quantifying bacterial translocation, supporting de-risking of anti-infective strategies aimed at preserving epithelial integrity. The method delivers quantitative, reproducible readouts that align with discovery-stage needs for predictive confidence in host-targeted therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses regarding pathogen traversal of epithelial barriers.
- Scientific Value: Supports functional validation of targets involved in barrier regulation or bacterial internalization.
- Scientific Value: Enhances predictive confidence by linking molecular mechanisms to phenotypic transcytosis outcomes.
Screening & Assay Development
- Scientific Value: Prepares validated epithelial monolayers for consistent, reproducible compound or antibody screening.
- Scientific Value: Enables standardization of transcytosis assays through TEER monitoring and time-point sampling.
- Scientific Value: Supports scalable platform use for evaluating barrier-modulating agents across multiple time points.
Translational & Preclinical Research
- Scientific Value: Models disease-relevant host-pathogen interactions in neonatal E. coli bacteremia.
- Scientific Value: Bridges discovery findings to preclinical continuity by quantifying barrier permeability changes.
- Scientific Value: Informs risk-adjusted advancement decisions based on transcytosis inhibition or enhancement profiles.
Pipeline & Workflow Integration
This transcytosis assay fits within the discovery continuum from target engagement screening to preclinical efficacy evaluation, particularly for pathogens exploiting host cellular transport mechanisms.
- Discovery Biology: Supports hypothesis testing of bacterial adhesion, invasion, and intracellular trafficking pathways.
- Screening: Delivers quantitative, time-resolved outputs for assessing compound effects on bacterial transport.
- Analytics: Generates colony-forming unit (CFU) counts and TEER trajectories as key readouts for condition comparison.
- Translational Research: Connects epithelial barrier function to preclinical models of neonatal sepsis.
- Enterprise Reuse: Establishes a reusable platform for screening barrier-protective or anti-virulence compounds.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic de-risking of targets involved in epithelial barrier modulation.
- Operational Value: Ensures assay reproducibility through electrical resistance monitoring and standardized sampling.
- Strategic Value: Improves go/no-go decisions by linking target modulation to functional barrier outcomes.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on transcytosis inhibition efficacy.
Implementation Considerations
- Requires expertise in cell culture, sterile technique, and transwell handling.
- Dependent on TEER measurement equipment and anaerobic or controlled incubation systems.
- Necessitates cross-team standardization of inoculation timing, sampling intervals, and CFU quantification.
- Adaptation considerations include epithelial cell source, pathogen strain variability, and vesicle trafficking inhibitors.
- Practical limitations include variability in monolayer formation and potential confounding effects of bacterial cytotoxicity on TEER.
Biopharma FAQs
Why does measuring electrical resistance matter for target validation in transcytosis assays?
Measuring electrical resistance (TEER) confirms monolayer integrity during the experiment, ensuring that observed bacterial transport reflects transcytosis rather than barrier disruption. This validation is critical for distinguishing specific transcytosis mechanisms from nonspecific leakage, supporting reliable target engagement assessment in early discovery.
How does isolating the independent variable (bacterial strain) support discovery pipeline objectives?
Isolating neonatal E. coli strains from bloodstream infections allows researchers to test specific pathogenic variables in a controlled epithelial model. This isolation enables attribution of transcytosis differences to bacterial factors rather than host variability, supporting target validation and mechanistic de-risking in antimicrobial development.
What do quantitative dependent variable measurements (CFU counts) enable in transcytosis studies?
Quantifying bacterial colonies from the lower well provides a direct measure of transcytosis efficiency over time, enabling comparison across experimental conditions. These CFU readouts support dose-response analysis and statistical evaluation of compounds or genetic modifications affecting bacterial transport.
Why are replication requirements important for cross-functional collaboration in transcytosis modeling?
Replication across time points and inserts ensures data reliability, which is essential for aligning discovery biology, screening, and preclinical teams on consistent barrier function metrics. Standardized replication reduces variability and strengthens confidence in translational decisions regarding anti-infective or barrier-protective candidates.
What statistical analysis capabilities are required before implementing transcytosis assays in a discovery workflow?
Implementation requires the ability to analyze time-dependent CFU data and TEER trajectories using appropriate statistical tests to compare control and treatment groups. These capabilities enable teams to assess significance of transcytosis modulation and support go/no-go decisions based on predefined efficacy thresholds.
08:24
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Related Videos
0 Views
08:00
Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine
Related Videos
0 Views
10:56
Endothelial Cell Transcytosis Assay as an In Vitro Model to Evaluate Inner Blood-Retinal Barrier Permeability
Related Videos
0 Views
18:57
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Related Videos
0 Views
11:27
Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D
Related Videos
0 Views
08:04
Real-time Measurement of Epithelial Barrier Permeability in Human Intestinal Organoids
Related Videos
0 Views
10:22
In Vitro and In Vivo Approaches to Determine Intestinal Epithelial Cell Permeability
Related Videos
0 Views
09:40
Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
Related Videos
0 Views
09:24
Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Related Videos
0 Views
06:43
Functional Assessment of Intestinal Tight Junction Barrier and Ion Permeability in Native Tissue by Ussing Chamber Technique
Related Videos
0 Views
Last updated: 18 July 2026